JP2019532275A5 - - Google Patents

Download PDF

Info

Publication number
JP2019532275A5
JP2019532275A5 JP2019511411A JP2019511411A JP2019532275A5 JP 2019532275 A5 JP2019532275 A5 JP 2019532275A5 JP 2019511411 A JP2019511411 A JP 2019511411A JP 2019511411 A JP2019511411 A JP 2019511411A JP 2019532275 A5 JP2019532275 A5 JP 2019532275A5
Authority
JP
Japan
Prior art keywords
group
hapten
target
carbon atoms
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019511411A
Other languages
English (en)
Japanese (ja)
Other versions
JP7033122B2 (ja
JP2019532275A (ja
Filing date
Publication date
Priority claimed from PCT/US2016/049153 external-priority patent/WO2017040349A1/en
Application filed filed Critical
Publication of JP2019532275A publication Critical patent/JP2019532275A/ja
Publication of JP2019532275A5 publication Critical patent/JP2019532275A5/ja
Application granted granted Critical
Publication of JP7033122B2 publication Critical patent/JP7033122B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019511411A 2015-08-28 2017-08-25 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ Active JP7033122B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562211590P 2015-08-28 2015-08-28
US201662301489P 2016-02-29 2016-02-29
USPCT/US2016/049153 2016-08-26
PCT/US2016/049153 WO2017040349A1 (en) 2015-08-28 2016-08-26 Protein proximity assay in formalin fixed paffafin embedded tissue using caged haptens
PCT/US2017/048687 WO2018039605A1 (en) 2015-08-28 2017-08-25 Protein proximity assay in formalin fixed paraffin embedded tissue using caged haptens

Publications (3)

Publication Number Publication Date
JP2019532275A JP2019532275A (ja) 2019-11-07
JP2019532275A5 true JP2019532275A5 (enExample) 2020-09-24
JP7033122B2 JP7033122B2 (ja) 2022-03-09

Family

ID=58188142

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018510803A Active JP6880001B2 (ja) 2015-08-28 2016-08-26 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ
JP2019511411A Active JP7033122B2 (ja) 2015-08-28 2017-08-25 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018510803A Active JP6880001B2 (ja) 2015-08-28 2016-08-26 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ

Country Status (7)

Country Link
US (6) US11053266B2 (enExample)
EP (1) EP3341734B1 (enExample)
JP (2) JP6880001B2 (enExample)
CN (3) CN107923915B (enExample)
AU (3) AU2016316846B2 (enExample)
CA (1) CA2996798A1 (enExample)
WO (2) WO2017040349A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107923915B (zh) 2015-08-28 2021-05-04 文塔纳医疗系统公司 使用经掩蔽的半抗原在福尔马林固定石蜡包埋的组织中的蛋白质邻近测定
WO2020121304A1 (en) * 2018-12-10 2020-06-18 Ariel Scientific Innovations Ltd. Therapeutic conjugates
CN110632040B (zh) * 2019-05-10 2022-03-29 长沙理工大学 一种血清中前列腺特异性抗原的分析方法
WO2021037869A1 (en) * 2019-08-28 2021-03-04 Ventana Medical Systems, Inc. Assessing antigen retrieval and target retrieval progression quantitation with vibrational spectroscopy
CN115552248A (zh) * 2020-05-07 2022-12-30 文塔纳医疗系统公司 用于评价肿瘤样品中egfr和egfr配体表达的组织化学系统和方法
EP4278181A1 (en) * 2021-01-15 2023-11-22 Ventana Medical Systems, Inc. Storage stable caged haptens
CN114994329A (zh) * 2022-04-28 2022-09-02 杭州广科安德生物科技有限公司 一种检测肿瘤组织中p185蛋白与p95蛋白表达水平的方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2730523A (en) * 1952-08-16 1956-01-10 Eastman Kodak Co 5-nitrothiazoleazo-n-fluoroalkyl-aniline compounds
WO1990000618A1 (en) 1988-07-08 1990-01-25 Jbl Scientific, Inc. Preparation and use of fluorescent benzothiazole derivatives
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
US5182203A (en) * 1989-03-29 1993-01-26 E. I. Du Pont De Nemours And Company Bifunctional compounds useful in catalyzed reporter deposition
US5180828A (en) * 1990-02-09 1993-01-19 Molecular Devices Corporation Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
US5595707A (en) 1990-03-02 1997-01-21 Ventana Medical Systems, Inc. Automated biological reaction apparatus
US5371241A (en) * 1991-07-19 1994-12-06 Pharmacia P-L Biochemicals Inc. Fluorescein labelled phosphoramidites
GB9517060D0 (en) * 1995-08-17 1995-10-25 Ciba Geigy Ag Acylated oligopeptide derivatives
US20030235877A1 (en) * 1996-04-30 2003-12-25 La Region Wallone Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
US20030211630A1 (en) 1998-02-27 2003-11-13 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
US6582962B1 (en) 1998-02-27 2003-06-24 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
EP2284543A3 (en) 1998-02-27 2015-05-27 Ventana Medical Systems, Inc. System and method of aspirating and dispensing reagent
US20060040319A1 (en) * 2000-01-14 2006-02-23 Tom Muir Multiple sensor-containing active modified polypeptides, preparation and uses thereof
EP1442296A4 (en) * 2001-08-07 2007-09-12 Merck & Co Inc BIOLOGICAL ASSAY DETECTION PROCEDURE
JP4950022B2 (ja) * 2004-03-23 2012-06-13 コンプレックス バイオシステムズ ゲーエムベーハー 自壊性リンカーを有する高分子プロドラッグ
WO2006116628A2 (en) 2005-04-28 2006-11-02 Ventana Medical Systems, Inc. Enzymes conjugated to antiobodies via a peg heterobifuctional linker
ES2548518T3 (es) 2005-11-23 2015-10-19 Ventana Medical Systems, Inc. Conjugado molecular
ES2905054T3 (es) 2006-11-01 2022-04-06 Ventana Med Syst Inc Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso
WO2008098100A2 (en) * 2007-02-07 2008-08-14 Perscitus Biosciences, Llc Detection of molecule proximity
JP2010528285A (ja) 2007-05-23 2010-08-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 免疫組織化学およびinsituハイブリダーゼーションのためのポリマー担体
WO2009018003A2 (en) * 2007-07-27 2009-02-05 Ensemble Discovery Corporation Detection assays and use thereof
AU2009282760B2 (en) 2008-08-22 2013-08-15 Ventana Medical Systems, Inc. Method for chromogenic detection of two or more target molecules in a single sample
JP5627698B2 (ja) 2009-10-19 2014-11-19 ベンタナ メディカル システムズ, インコーポレイテッド 撮像システムおよび技法
CA2782009C (en) * 2009-11-27 2017-10-03 Ecole Polytechnique Federale De Lausanne (Epfl) Nanofluidic biosensor and its use for rapid measurement of biomolecular interactions in solution and methods
EP2659000B1 (en) 2010-12-30 2016-08-10 Ventana Medical Systems, Inc. Enhanced deposition of chromogens utilizing pyrimidine analogs
US8852599B2 (en) * 2011-05-26 2014-10-07 Bristol-Myers Squibb Company Immunoconjugates, compositions for making them, and methods of making and use
CA2928374C (en) 2011-09-09 2018-09-25 Ventana Medical Systems, Inc. Imaging systems, cassettes, and methods of using the same
CA2867144C (en) 2012-03-27 2019-07-02 Ventana Medical Systems, Inc. Signaling conjugates and methods of use
EP2971064B1 (en) * 2013-03-12 2019-10-16 Ventana Medical Systems, Inc. Proximity assay for in situ detection of targets
CN103513039B (zh) * 2013-07-10 2015-12-23 广州美格生物科技有限公司 一种利用定向肽库检测蛋白质与其他分子相互作用的方法
US10241115B2 (en) * 2013-12-10 2019-03-26 Merck Sharp & Dohme Corp. Immunohistochemical proximity assay for PD-1 positive cells and PD-ligand positive cells in tumor tissue
WO2015124703A1 (en) * 2014-02-24 2015-08-27 Ventana Medical Systems, Inc. Quinone methide analog signal amplification
WO2015153401A1 (en) * 2014-04-04 2015-10-08 Merck Sharp & Dohme Corp Phosphate based linkers for intracellular delivery of drug conjugates
EP3224621B1 (en) * 2014-11-25 2019-06-12 Ventana Medical Systems, Inc. Proximity assays using chemical ligation and hapten transfer
EP3037820A1 (en) * 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Cell detection methods and reagents having a releasable labelling moiety
CN107923915B (zh) * 2015-08-28 2021-05-04 文塔纳医疗系统公司 使用经掩蔽的半抗原在福尔马林固定石蜡包埋的组织中的蛋白质邻近测定

Similar Documents

Publication Publication Date Title
JP2019532275A5 (enExample)
CA1338320C (en) Resorufin derivatives
US3905871A (en) Lactam conjugates to enzymes
US8703417B2 (en) Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
KR100259144B1 (ko) 포스파타제와의 반응에 의해 화학발광을 생성하는 화합물, 조성물 및 방법
US9029092B2 (en) Solution phase homogeneous assays
US4550163A (en) Ligand analog-irreversible enzyme inhibitor conjugates
JP2024083477A (ja) 化学発光基質
US4578361A (en) Creatinine antibody
US8916346B2 (en) Reagents and methods for direct labeling of nucleotides
US20100273189A1 (en) Non separation assays with selective signal inhibitors
JPH07502559A (ja) 化学発光ブロット法に適用するための改良された膜
CA2353872A1 (en) Multiple enzyme assays
WO1995017672A1 (en) Chemiluminescent energy transfer assays
JPS60256398A (ja) 試験試料中の白血球、エステラーゼ又はプロテアーゼの存在を測定するための組成物及び試験具
JPH02504109A (ja) 酵素活性測定方法
JP2004294443A (ja) Hivプロテアーゼインヒビターの免疫測定法
JP2018528425A5 (enExample)
CN107652344B (zh) 化合物、缀合物、试剂盒及其在检测睾酮或其类似物中的用途
JP3190730B2 (ja) 新規標識薬物ハプテン類似体を用いるイムノアッセイ
US4595656A (en) Coupling agents and products produced therefrom
US4543325A (en) Process and reagent for the determination of creatinine
US5948630A (en) Method and composition for reducing the effects of endogenous alkaline phosphatase
RU2102759C1 (ru) Способ обнаружения или количественного определения аналита в образце
GB2050602A (en) Method of and reagents for quantitative determination of cyclic nucleotides